Health ❯ Biotechnology

Drug Development

Clinical Trials Gene Therapy Viral Hepatitis Molecular Transport Company Closures Clinical Testing AI in Healthcare Clinical Efficacy Weight Loss Drugs Cancer Treatment Cardiovascular Drugs Protein Applications Obesity Treatments Alzheimer's Drugs Cancer Research Biologics Research Investments Vaccine Design Allosteric Modulators Antibodies Protein Therapeutics Press Releases Biosimilars Neurodegenerative Disorders Regulatory Affairs Monoclonal Antibodies Therapeutics

Nuclera Extends Series C to $87 Million to Accelerate Full-Format Antibody Workflows

The company targets AI-ready, standardized protein datasets by building end-to-end antibody capabilities into its benchtop eProtein Discovery platform.

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Prolynx Raises $70 Million to Advance Ultra-Long-Acting Obesity Drugs

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug

Lilly and Breakthrough to Open Gateway Labs Biotech Incubator at 2300 Market in Philadelphia

FDA Flags Possible License Revocation for Sarepta’s Elevidys